Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human fetal cortical stem cell cultures | Human | brain | stem cell | adherent | plasmid | Metafectene | publication | S. Couillard-Despres et al., 2014, US 8,841,430 | Link | ||||
Human primary fibroblasts | Human | unknown | primary cell | siRNA | RNA-Interference | Metafectene | publication | L. Woodbine et al., Nucleic Acids Res., Sep 2011; 39: 6986 - 6997 | Link | ||||
Human tenon’s capsule fibroblasts | Human | sensory organs | unknown | oligonucleotide | Metafectene | publication | H. Mietz et al., Invest. Ophthalmol. Vis. Sci., May 2003; 44: 4290 | ||||||
Human primary skin fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Milani et al., ResearchSquare, 2021, doi.org/10.21203/rs.3.rs-138253/v1 | Link | |||
Human primary chronic lymphocytic leukemia cells | Human | immune system | primary cell | suspension | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Haematologica, Jul 2008; 93: 1039 - 1048 | Link | |||
Human fibrous dysplasia cells | Human | unknown | unknown | plasmid | Metafectene | publication | P. Orth et al., Mol Biotechnol, Feb 2008; 38(2): 137-44 | ||||||
Human Praeadipocytes | Human | skin | primary cell | plasmid | Metafectene | publication | G. Weisinger et al., US9663790B2 | Link | |||||
Primary human skin fibroblasts | Human | skin | primary cell | adherent | plasmid | Metafectene | publication | T. Kiel, Dissertation 2012, Julius-Maximilians-Universität Würzburg | |||||
Human keratinocytes isolated from neonatal foreskin | Human | skin | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Bruche, PhD Thesis, 2014, Imperial College London | Link | |||
Human primary fibroblasts (derived from ALS patients) | Human | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Milani et al., J. of Neuroinflammation, 2021, 18: 132, doi.org/10.1186/s12974-021-02184-1 | Link | |||
143B |
Human osteosarcoma cell line | ATCC CRL-8304 | Human | bone | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
184A1 |
Human immortalized mammary epithelial cells | ATCC CRL-8798 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | K. Konopka et al., Cell Mol Biol Lett, Jan 2009; 14(1): 70-89 | |||
1BR3hTERT |
Human hTERT immortalized fibroblasts | Human | unknown | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | T. Stiff et al., Hum. Mol. Genet., Apr 2016; 25: 1574 - 1587 | Link | ||
22Rv1 |
Human prostate epithelial cancer cell line | ATCC CRL-2505 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | M. Ansems et al., The Prostate, 2012, 72: 1708-1717, DOI 10.1002/pros.22522 | |||
293-EBV |
Human embryonic kidney cell line stably carrying recombinant EBV genome (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | B. Neuhierl et al., J. Virol., May 2009; 83: 4616 - 4623 | Link | ||
293-EBV |
Human embryonic kidney cell line stably carrying recombinant EBV genome (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | R. Gonnella et al., Bioch. et Biophys. Acta, 2015, 1853: 1586-1595; doi.org/10.1016/j.bbamcr.2015.03.011 | Link | ||
293-EBV |
Human embryonic kidney cell line stably carrying recombinant EBV genome (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | H. Nowag et al., EBioMedicine, 2014, 1 :116-125, doi.org/10.1016/j.ebiom.2014.11.007 | Link | ||
293-EBV |
Human embryonic kidney cell line stably carrying recombinant EBV genome (derivat of HEK293) | Human | urinary system | cell line | plasmid | Metafectene | publication | S. Barth et al., Nucleic Acids Res., Feb 2008; 36: 666 - 675 | Link | ||||
293-EBV |
Human embryonic kidney cell line stably carrying recombinant EBV genome (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | R. Feederle et al., J. Virol., May 2009; 83: 4952 - 4962 | Link | ||
293-EBV |
Human embryonic kidney cell line stably carrying recombinant EBV genome (derivat of HEK293) | Human | urinary system | cell line | plasmid | Metafectene | publication | M. Granato et al., J. Virol., Apr 2008; 82: 4042 - 4051 | Link | ||||
293-EBV |
Human embryonic kidney cell line stably carrying recombinant EBV genome (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | R. Feederle et al., J. Virol., Nov 2009; 83: 10877 - 10891 | Link | ||
293-TLR3 |
Human embryonic kidney cell line stably expressing TLR3 (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | R. Higgs et al., J. Immunol., Aug 2008; 181: 1780 - 1786 | Link | ||
293-TLR4/MD2 |
Human embryonic kidney cell line stably expressing TLR4/MD2 (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | R. Higgs et al., J. Immunol., Aug 2008; 181: 1780 - 1786 | Link | ||
293/2089 |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | S. Iskra et al., J. Virol., Apr 2010; 84: 3612 - 3623 | Link | ||
293/delta BALF4 |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | B. Neuhierl et al., J. Virol., May 2009; 83: 4616 - 4623 | Link |